Caxton Associates (New York)’s Amdocs DOX Stock Holding History
Bought
Maintained
Sold
Other funds holding DOX
BGC
Caxton Associates (New York)'s DOX Position: Q3 2020 in Review
Caxton Associates (New York) sold out of Amdocs (DOX) in Q3 2020, closing a stake of 4,963 shares — an estimated $302K sold.
Caxton Associates (New York) first reported a position in DOX in Q2 2013 and held it in 8 quarters. The position peaked at $2.79M in Q1 2014. 395 funds tracked by Wall St. Rank hold DOX as of Q3 2020.
- Caxton Associates (New York) reported no remaining Amdocs position as of Q3 2020 after selling out during the quarter.
- Caxton Associates (New York) sold 4,963 Amdocs shares in Q3 2020, an estimated $302K.
- Caxton Associates (New York) first reported a position in Amdocs in Q2 2013 and held it in 8 quarters.
- Caxton Associates (New York)'s Amdocs position peaked at $2.79M in Q1 2014.
- 395 funds tracked by Wall St. Rank held Amdocs as of Q3 2020.
Based on Caxton Associates (New York)'s 13F filing for Q3 2020, filed 16 Nov 2020.